Trademarkia Logo

Australia

AU$
REVUFORJ
Protected: Registered/protected

Last updated on 19 Oct 2023

Owner Info

Syndax Pharmaceuticals, Inc.

35 Gatehouse Drive, Building D, Floor 3

Waltham MA 02451, UNITED STATES OF AMERICA

Serial Number

2379027 filed on 14 Jul 2023

Correspondent

John Paul Oleksiuk Cooley LLP

1299 Pennsylvania Ave NW,,

Suite 700,

UNITED STATES OF AMERICA

REVUFORJ

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cancer.

Class [042]
Research and development of pharmaceuticals for the treatment of cancer; medical and scientific research services in the field of cancer treatment.

Class [044]
Providing information in the field of cancer treatment; providing links to the web sites of others featuring information about the diagnosis and treat Read More

Mark Details


Serial Number

2379027

Registered On

14 Jul 2023

Renewal On

14 Jul 2033

Mark Type

WORD

Priority Claim (Convention Details)


Date

19 Jan 2023

Mark Type

US

Legal History


Show more

Status DateAction Taken
19th Oct 2023International Registration in Australia Protected correspondence sent
18th Oct 2023IP Right Registration Published
18th Oct 2023Status change to Registered/Protected
12th Aug 2023Application Accepted correspondence sent
11th Aug 2023IP Right has been Examined
11th Aug 2023IP Right Acceptance Published
11th Aug 2023Status change to Accepted
11th Aug 2023Awaiting examination
11th Aug 2023Examination expedited
10th Aug 2023IP Right Filed Published